StockWatch: J&J Settles for $230m!

Johnson & Johnson has agreed to a $230 million settlement with the state of New York, over the company’s role in the opioid epidemic.

A New York lawsuit against the makers and distributors of opioids is going to trial next week. Johnson & Johnson was set to be a defendant, but will no longer be a part of the trial due to the settlement agreement.

The US FDA added a warning to patient and provider fact sheets for the Pfizer and Moderna Covid19 vaccines, to indicate a rare risk of heart inflammation.

Nonetheless, health officials said the benefits of receiving the vaccine still outweigh any risk.

So will governments ever stop vaccines completely?

Timestamps:

• #PFE 02:30
• #JNJ 03:50

Trade over 200 of the hottest stock CFDs with spreads starting from 0.0 pips - Open your Orbex account today!